BMS initiates first round of layoffs in New Jersey
The company has resumed dismissing employees as part of an ongoing workforce reduction of about 10%.
If you are not happy with the results below please do another search
The company has resumed dismissing employees as part of an ongoing workforce reduction of about 10%.
The European Commission launched a probe into China’s public procurement of medical devices, the latest in a series of moves that ratchet up trade tensions ahead of President Xi Jinping’s visit to Europe next month.
Overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk’s weight-loss drug Wegovy, a study published by Kaiser Family Foundation showed on Wednesday.
The commercial is part of a joint initiative of the National Hockey League and National Hockey League Players’ Association in support of Hockey Fights Cancer.
Novartis has been hit with a lawsuit by people with autism and their mothers alleging the drugmaker illegally promoted an asthma drug for treatment of preterm labor despite knowing it was ineffective and could cause abnormal fetal brain development.
With a distinguished and award-winning career at companies such as Ogilvy Health and McCann Health, Basque brings creative support, refined technique, and 25 years of expertise to The Bloc, further strengthening its commitment to health communication excellence.
Yesterday the agency denied approval for Abeona Therapeutics’ investigational gene-corrected cell therapy prademagene zamikeracel (pz-cel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare disease that causes painful blistering and erosion of the skin.
CEO Hervé Hoppenot said on an investor call that Escient Pharmaceuticals’ two lead assets “address large populations with a clear medical need” with a potential multibillion-dollar market opportunity.
DeViteri previously spent nearly 20 years at Inizio Evoke Comms and returns after close to two years at MSL, where she successfully partnered with leadership to strengthen and grow its health practice. Over the course of her career, she’s led the creation and execution of countless health communications programs and initiatives, with people and communities always at the center.
Data from the Phase III LUNA 3 study on Tuesday showed that Sanofi’s BTK inhibitor rilzabrutinib significantly improved durable platelet response in patients with chronic immune thrombocytopenia.